Financial results - NOVO CONSULTING & CLINICAL RESEARCH SERVICES SRL

0.00
Financial Summary - Novo Consulting & Clinical Research Services Srl
Unique identification code: 34055353
Registration number: J40/1236/2015
Nace: 4619
Sales - Ron
53.298
Net Profit - Ron
28.660
Employee
1
Open Account
The most important financial indicators for the company Novo Consulting & Clinical Research Services Srl - Unique Identification Number 34055353: sales in 2023 was 53.298 euro, registering a net profit of 28.660 euro and having an average number of 1 employees. Firma isi desfasoara activitatea in domeniul Intermedieri in comertul cu produse diverse having the NACE code 4619.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Novo Consulting & Clinical Research Services Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR - 23.147 28.263 26.093 24.491 24.306 25.582 25.096 40.199 53.298
Total Income - EUR - 23.147 28.263 26.093 24.491 24.306 25.582 25.096 40.199 53.298
Total Expenses - EUR - 14.072 14.475 9.399 14.889 17.520 17.440 29.271 23.960 24.116
Gross Profit/Loss - EUR - 9.076 13.789 16.694 9.602 6.786 8.142 -4.175 16.240 29.182
Net Profit/Loss - EUR - 8.381 12.941 16.047 9.357 6.543 7.898 -4.421 15.846 28.660
Employees - 0 0 1 1 1 1 1 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 33.0%, from 40.199 euro in the year 2022, to 53.298 euro in 2023. The Net Profit increased by 12.862 euro, from 15.846 euro in 2022, to 28.660 in the last year.
See Company Data

Check the financial reports for the company - Novo Consulting & Clinical Research Services Srl

Rating financiar

Rating financiar -
Novo Consulting & Clinical Research Services Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Novo Consulting & Clinical Research Services Srl - CUI 34055353

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 0 0 0 0 0 0 0 0 0 -
Current Assets - 9.121 13.205 29.270 38.056 43.963 51.247 45.541 50.437 56.270
Inventories - 0 0 0 0 0 0 38 39 0
Receivables - 981 13.100 27.534 36.768 43.200 50.079 45.140 49.596 54.531
Cash - 8.140 104 1.736 1.288 763 1.167 362 803 1.739
Shareholders Funds - 8.426 12.985 28.812 37.641 43.455 50.529 44.988 48.550 55.748
Social Capital - 45 45 44 43 42 41 40 41 40
Debts - 694 219 458 415 508 718 553 1.887 523
Income in Advance - 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "4619 - 4619"
CAEN Financial Year 4619
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 56.270 euro in 2023 which includes Inventories of 0 euro, Receivables of 54.531 euro and cash availability of 1.739 euro.
The company's Equity was valued at 55.748 euro, while total Liabilities amounted to 523 euro. Equity increased by 7.345 euro, from 48.550 euro in 2022, to 55.748 in 2023.
Monitors the Company

Activate a subscription with unlimited access and get contact details for any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Recurring - monthly payment

Pay

25,21 EUR / month
NELIMITAT

Reports that can be accessed based on the subscription:

  • ✔ Financial Rating
  • ✔ Payment Limits
  • ✔ Outstanding Debts
  • ✔ Probability of Insolvency
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
See Subscriptions

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.